Live Chat

交易 Bristol Myers BMY

BristolMyers實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期  關閉 更改 更改(%): 開倉

最新新聞

Christine Voong 2024 Nov 22, 09:20

黃金價格走勢强勁突破2,688美元,地緣政治風險與科技股反彈推動市場波動

Christine Voong 2024 Nov 22, 07:20

原油價格走勢強勁,OPEC+增產推遲與烏俄衝突推升市場風險

Christine Voong 2024 Nov 22, 04:26

美股指數期貨下跌,字母控股公司虧損施壓科技股,利率疑慮持續影響市場

So Ze Dong 2024 Nov 22, 01:00

11月22日財經:美股三大指數表現不一,比特幣價格飆升至99000美元

Christine Voong 2024 Nov 21, 10:18

華為晶片Ascend 910C計劃2025年量產,面臨美國禁令與台積電供應挑戰

Christine Voong 2024 Nov 21, 08:05

黃金價格走勢:俄烏衝突推動黃金價格上漲,美元與利率預期施壓金價

Christine Voong 2024 Nov 21, 04:13

美元匯率回升,美元指數攀升至一年高點,市場焦點轉向川普政策與聯準會

So Ze Dong 2024 Nov 20, 16:00

11月21日財經:輝達財報亮眼卻股價下跌,美股指數表現平平

聯絡方式

點差

0.37

點差(%)

0.6301 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期一

14:31 - 20:59

星期二

14:31-20:59

星期三

14:31-20:59

星期四

14:31-20:59

星期五

14:31-20:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

119398948864

流通股份

2028179968

收益日期(下一個)

2001-08-07

現金殖利率 

2024-11-01

除息日

2024-10-04

遠期年股息率

2.4

遠期年現金殖利率

0.0412

每股盈餘

-3.58

了解有關此金融工具的詳細資訊

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

相關工具

資產
出售
購買
更改(%):
查看所有金融工具
Trustpilot
Live Chat